RP-3467

N/A

Report date: 2026/01/18 20:00:10
NME

Base Information

Drug NameRP-3467
Drug Alias NameRP-3467
ClassificationSmall molecules
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRepare Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncRepare Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A